tirzepatide press release A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.⁠ ⁠ The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or Tirzepatide for the Maintenance of

The first week felt pretty much the same

Ear biometrics for patient identification in global health: a field study to test the effectiveness of an image stabilization device in improving identification accuracy

Safety, regulation, and product quality Dietary supplements are regulated differently from prescription medicines

The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)

Ibrahim Suggests

Considerations for Semaglutide Semaglutide, while a valuable medication for body weight management and blood sugar control, is not without safety considerations